ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.

Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer diagnosed in Asian countries, with its incidence on the rise. Cancer stem cell (CSC; also known as tumor-initiating cells, TIC) is inherently resistant to cytotoxic chemotherapy and radiation and associates with po...

Full description

Bibliographic Details
Main Authors: Sheng-Ta Tsai, Po-Jen Wang, Nia-Jhen Liou, Pei-Shan Lin, Chung-Hsuan Chen, Wei-Chao Chang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4646358?pdf=render
_version_ 1818135756657393664
author Sheng-Ta Tsai
Po-Jen Wang
Nia-Jhen Liou
Pei-Shan Lin
Chung-Hsuan Chen
Wei-Chao Chang
author_facet Sheng-Ta Tsai
Po-Jen Wang
Nia-Jhen Liou
Pei-Shan Lin
Chung-Hsuan Chen
Wei-Chao Chang
author_sort Sheng-Ta Tsai
collection DOAJ
description Esophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer diagnosed in Asian countries, with its incidence on the rise. Cancer stem cell (CSC; also known as tumor-initiating cells, TIC) is inherently resistant to cytotoxic chemotherapy and radiation and associates with poor prognosis and therapy failure. Targeting therapy against cancer stem cell has emerged as a potential therapeutic approach to develop effective regimens. However, the suitable CSC marker of ESCC for identification and targeting is still limited. In this study, we screened the novel CSC membrane protein markers using two distinct stemness characteristics of cancer cell lines by a comparative approach. After the validation of RT-PCR, qPCR and western blot analyses, intercellular adhesion molecule 1 (ICAM1) was identified as a potential CSC marker of ESCC. ICAM1 promotes cancer cell migration, invasion as well as increasing mesenchymal marker expression and attenuating epithelial marker expression. In addition, ICAM1 contributes to CSC properties, including sphere formation, drug resistance, and tumorigenesis in mouse xenotransplantation model. Based on the analysis of ICAM1-regulated proteins, we speculated that ICAM1 regulates CSC properties partly through an ICAM1-PTTG1IP-p53-DNMT1 pathway. Moreover, we observed that ICAM1 and CD44 could have a compensation effect on maintaining the stemness characteristics of ESCC, suggesting that the combination of multi-targeting therapies should be under serious consideration to acquire a more potent therapeutic effect on CSC of ESCC.
first_indexed 2024-12-11T09:29:34Z
format Article
id doaj.art-54fb4e9f5d9d4160ab40692eea1ea770
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T09:29:34Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-54fb4e9f5d9d4160ab40692eea1ea7702022-12-22T01:13:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014283410.1371/journal.pone.0142834ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.Sheng-Ta TsaiPo-Jen WangNia-Jhen LiouPei-Shan LinChung-Hsuan ChenWei-Chao ChangEsophageal squamous cell carcinoma (ESCC) accounts for about 90% of esophageal cancer diagnosed in Asian countries, with its incidence on the rise. Cancer stem cell (CSC; also known as tumor-initiating cells, TIC) is inherently resistant to cytotoxic chemotherapy and radiation and associates with poor prognosis and therapy failure. Targeting therapy against cancer stem cell has emerged as a potential therapeutic approach to develop effective regimens. However, the suitable CSC marker of ESCC for identification and targeting is still limited. In this study, we screened the novel CSC membrane protein markers using two distinct stemness characteristics of cancer cell lines by a comparative approach. After the validation of RT-PCR, qPCR and western blot analyses, intercellular adhesion molecule 1 (ICAM1) was identified as a potential CSC marker of ESCC. ICAM1 promotes cancer cell migration, invasion as well as increasing mesenchymal marker expression and attenuating epithelial marker expression. In addition, ICAM1 contributes to CSC properties, including sphere formation, drug resistance, and tumorigenesis in mouse xenotransplantation model. Based on the analysis of ICAM1-regulated proteins, we speculated that ICAM1 regulates CSC properties partly through an ICAM1-PTTG1IP-p53-DNMT1 pathway. Moreover, we observed that ICAM1 and CD44 could have a compensation effect on maintaining the stemness characteristics of ESCC, suggesting that the combination of multi-targeting therapies should be under serious consideration to acquire a more potent therapeutic effect on CSC of ESCC.http://europepmc.org/articles/PMC4646358?pdf=render
spellingShingle Sheng-Ta Tsai
Po-Jen Wang
Nia-Jhen Liou
Pei-Shan Lin
Chung-Hsuan Chen
Wei-Chao Chang
ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
PLoS ONE
title ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
title_full ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
title_fullStr ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
title_full_unstemmed ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
title_short ICAM1 Is a Potential Cancer Stem Cell Marker of Esophageal Squamous Cell Carcinoma.
title_sort icam1 is a potential cancer stem cell marker of esophageal squamous cell carcinoma
url http://europepmc.org/articles/PMC4646358?pdf=render
work_keys_str_mv AT shengtatsai icam1isapotentialcancerstemcellmarkerofesophagealsquamouscellcarcinoma
AT pojenwang icam1isapotentialcancerstemcellmarkerofesophagealsquamouscellcarcinoma
AT niajhenliou icam1isapotentialcancerstemcellmarkerofesophagealsquamouscellcarcinoma
AT peishanlin icam1isapotentialcancerstemcellmarkerofesophagealsquamouscellcarcinoma
AT chunghsuanchen icam1isapotentialcancerstemcellmarkerofesophagealsquamouscellcarcinoma
AT weichaochang icam1isapotentialcancerstemcellmarkerofesophagealsquamouscellcarcinoma